Drug companies cheat ill consumers with sickening greed

Thank you for printing the article about how to save money on drug costs (Sept. 15).

One of Obamacare’s biggest failures is neglecting to control drug costs as well and allowing pharmaceutical companies to turn their drugs into money-printing machines. Failing to regulate the companies has made consumers pay the price.

Doxycycline is a perfect example. This is a common medication for acne and should cost a dollar a day when the generic is taken four times a day. The extended-release form taken once a day is, as the article states, $1,800 per month.

What happened to the companies making the generic? They were bought out by the company making the extended-release form. When government allows this to happen, the consumer will always lose. The little suggestions to save money help, but we need someone to stop problems at their source.

This story was originally published September 18, 2015 at 9:18 AM with the headline "Drug companies cheat ill consumers with sickening greed."